Working… Menu

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00228592
Recruitment Status : Terminated
First Posted : September 29, 2005
Last Update Posted : February 13, 2007
Information provided by:
Cubist Pharmaceuticals LLC

No Study Results Posted on for this Study
Recruitment Status : Terminated
Primary Completion Date : No date given
Study Completion Date : August 2005